Annual ONS Congress Archives - Research to Practice

Upcoming events

No upcoming events found.

Past events

May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL

Upcoming events

Past events

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL